GB Sciences, with the first cannabis crop now in production at their high-tech 36,000 square-foot grow facility in Baton Rouge, and teams from GB Sciences and the LSU AgCenter are working closely with Louisiana pharmacists who will serve patients starting in November.
Approximately three years after the passage of the Alison Neustrom Act, the Louisiana Pharmacy Board has issued permits to nine pharmacists who will dispense medical marijuana in their nine respective regions of the state with a potential 10th license to be awarded at a later date in a high-demand area.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!
Patients must have a prescription from a physician for a qualifying medical condition. Pharmacists will dispense formulations in the form of pills, oils, and topical solutions. None of the cannabis formulation may be smoked.
Qualifying Disease States
- Cancer
- HIV/AIDS
- Cachexia or wasting syndrome
- Seizure disorders
- Epilepsy
- Spasticity
- Crohn's disease
- Muscular dystrophy
- Multiple sclerosis
- PTSD
- Glaucoma
- Parkinson's disease
- Severe muscle spasms
- Intractable pain
- Autism spectrum disorder
On August 9th, representatives from the nine pharmacies toured the high-tech GB Sciences facility in Baton Rouge, LA.
"We looked at the grow rooms, processing, spoke with a number of the executives there, all very knowledgeable … a state-of-the-art facility," said John Condos, a Louisiana business owner. "Security was unbelievable, all of which shows me that GB Sciences is committed to making this process in Louisiana a success."
"I'm just excited to be able to offer a new opportunity to patients," said Randy Mire, a pharmacist who will serve patients in and around Baton Rouge. "This is a much-needed medication that I think many people can benefit from and to be able to offer that in Louisiana is just something I'm so proud of."